Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AMDL has announced that its subsidiary Jade Pharmaceutical, anticipates releasing two new formulations of its Goodnak anti-aging skin care product line during the third quarter of 2008.
Subscribe to our email newsletter
In addition to its injectable formulation, Jade Pharmaceutical (JPI) anticipates offering Goodnak in capsules and an easy-to-apply lotion.
Based on general market information, the proposed pricing for these new formulations will be approximately $40 per unit, with 60% gross profit margins. JPI plans to sell both products through existing distribution channels within the Henan, Sichuan, Guizhou, Shanxi, Xinjiang, Gansu, Hunnan, Zhejiang, Fujian, Liaoning and Heilongjiang Provinces of China.
In addition to China, AMDL believes both products will be good candidates for export to the North American and European markets.